It’s premature to draw conclusions about the potential of treating inflamed tendons with stem cells based on this very preliminary work.
The release should have been more clear that this study has significant limitations in both sample size and duration of effect and that nothing is known about whether this effect can be repeated usefully, reliably or safely.
Although the release includes a cautionary quote at the end calling for further study, the headline is far too optimistic for a small study of brief duration.
Without numbers and definitions, the reader is given little context for understanding the benefits of pasta in a kid’s diet.
A new blood test “substantially reduces” the need for biopsy, but by how much really? Benefit data are given only in relative terms in this news release.
The study compared people in treatment for opioid use disorder with those with no previous substance abuse history. A better comparator would have been people who used opioids for pain without becoming addicted.
This release would have been greatly improved with a caution that pre-clinical animal research often doesn’t pan out in people.
Short-term case studies of two patients, even very encouraging ones, don’t equal effective treatment for broad populations of patients, and the news release needed to spell that out.